Matthew Stanton
Stock Analyst at Jefferies
(0.20)
# 4,043
Out of 4,818 analysts
5
Total ratings
33.33%
Success rate
-38.22%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $5.65 | +41.59% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.24 | +163.16% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $24.48 | -10.13% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $26.45 | +141.97% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $5.65
Upside: +41.59%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.24
Upside: +163.16%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $24.48
Upside: -10.13%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $26.45
Upside: +141.97%